Combination Chemotherapy in Treating Patients With Advanced Ovarian Epithelial Cancer

Completed · Phase 2

Conditions studied: Ovarian Cancer

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy in treating patients who have advanced ovarian epithelial cancer.

Key facts

Study ID

NCT00005051

Run by

NYU Langone Health

Starts

1999-08-01

Last updated by the study team

2012-11-09

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

Where it is running

• New York Hospital Medical Center of Queens — Fresh Meadows, New York, United States
• Saint Vincent Catholic Medical Center of New York — New York, New York, United States
• NYU School of Medicine's Kaplan Comprehensive Cancer Center — New York, New York, United States
• St. Luke's-Roosevelt Hospital Center - Roosevelt Division — New York, New York, United States
• New York Weill Cornell Cancer Center at Cornell University — New York, New York, United States
• Mount Sinai Medical Center, NY — New York, New York, United States
• Herbert Irving Comprehensive Cancer Center at Columbia University — New York, New York, United States
• Albert Einstein Clinical Cancer Center — The Bronx, New York, United States
• New York Medical College — Valhalla, New York, United States
• University of Wisconsin Comprehensive Cancer Center — Madison, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.